Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Nadir CA125 concentration as a prognostic indicator in ovarian cancer

Nature Clinical Practice Oncology volume 2, pages 288–289 (2005)Cite this article

Access through your institution
Buy or subscribe

boxed-textCrawford SM and Peace J (2005) Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol 16: 47–50

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Meyer T and Rustin GJ (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 82: 1535–1538

    Article  CAS  Google Scholar 

  2. Fritsche HA and Bast RC (1998) CA 125 in ovarian cancer: advances and controversy. Clin Chem 44: 1379–1380

    CAS  PubMed  Google Scholar 

  3. Rustin GJS et al. (2001) Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol 19: 4054–4057

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor of Hematology/Oncology at the University of Kentucky, in the Markey Cancer Center, College of Public Health, Lexington, KY, USA

    Andre T Baron

  2. Professor of Obstetrics, Gynecology & Reproductive Sciences, Pathology and Pharmacology at Yale University School of Medicine, New Haven, CT, USA

    Nita Maihle

Authors
  1. Andre T Baron
    View author publications

    Search author on:PubMed Google Scholar

  2. Nita Maihle
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Nita Maihle.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Glossary

CA125

Cancer antigen 125

NADIR

The lowest point

FIGO

Federation of Gynecology and Obstetrics

INSTITUTIONAL REVIEW BOARD (IRB)

A group of scientists, doctors, clergy, and consumers at each health care facility that participates in a clinical trial to protect study participants

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baron, A., Maihle, N. Nadir CA125 concentration as a prognostic indicator in ovarian cancer. Nat Rev Clin Oncol 2, 288–289 (2005). https://doi.org/10.1038/ncponc0178

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncponc0178

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing